Literature DB >> 16819396

Defects in bile acid biosynthesis--diagnosis and treatment.

Kenneth D R Setchell1, James E Heubi.   

Abstract

Bile acid synthetic defects represent a specific category of metabolic liver disease. This article highlights the history and summarizes our analytical approach to the diagnosis and treatment of genetic defects in bile acid synthesis. By the application of mass spectrometry as a screening tool, it is possible to perform rapid diagnosis of potential inborn errors in bile acid synthesis from urinary bile acid analysis. Molecular techniques then afford the identification of specific mutations in genes encoding the enzymes responsible for bile acid synthesis. Using this approach, 6 of the 7 known genetic defects that are causes of progressive cholestatic liver disease, syndromes of fat-soluble vitamin malabsorption, or neurological disease, have been characterized. Bile-acid therapy using oral cholic acid has proven effective in most of these bile acid synthetic defects making early diagnosis crucial to optimum clinical prognosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16819396     DOI: 10.1097/01.mpg.0000226386.79483.7b

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  29 in total

1.  Prognostic roles of tetrahydroxy bile acids in infantile intrahepatic cholestasis.

Authors:  Chee-Seng Lee; Akihiko Kimura; Jia-Feng Wu; Yen-Hsuan Ni; Hong-Yuan Hsu; Mei-Hwei Chang; Hiroshi Nittono; Huey-Ling Chen
Journal:  J Lipid Res       Date:  2017-01-10       Impact factor: 5.922

2.  Genetic defects in bile acid conjugation cause fat-soluble vitamin deficiency.

Authors:  Kenneth D R Setchell; James E Heubi; Sohela Shah; Joel E Lavine; David Suskind; Mohammed Al-Edreesi; Carol Potter; David W Russell; Nancy C O'Connell; Brian Wolfe; Pinky Jha; Wujuan Zhang; Kevin E Bove; Alex S Knisely; Alan F Hofmann; Philip Rosenthal; Laura N Bull
Journal:  Gastroenterology       Date:  2013-02-13       Impact factor: 22.682

3.  Serum Unconjugated Bile Acids and Small Bowel Bacterial Overgrowth in Pediatric Intestinal Failure: A Pilot Study.

Authors:  David Galloway; Ethan Mezoff; Wujuan Zhang; Melissa Byrd; Conrad Cole; Inmaculada Aban; Samuel Kocoshis; Kenneth Dr Setchell; James E Heubi
Journal:  JPEN J Parenter Enteral Nutr       Date:  2018-07-23       Impact factor: 4.016

4.  Primary ∆4-3-oxosteroid 5β-reductase deficiency: two cases in China.

Authors:  Jing Zhao; Ling-Juan Fang; Kenneth D R Setchell; Rui Chen; Li-Ting Li; Jian-She Wang
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

Review 5.  Bile acids: analysis in biological fluids and tissues.

Authors:  William J Griffiths; Jan Sjövall
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

6.  Cholic acid for hepatic steatosis in patients with lipodystrophy: a randomized, controlled trial.

Authors:  Zahid Ahmad; Lalitha Subramanyam; Lidia Szczepaniak; Vinaya Simha; Beverley Adams-Huet; Abhimanyu Garg
Journal:  Eur J Endocrinol       Date:  2013-04-15       Impact factor: 6.664

Review 7.  Bile acids: the role of peroxisomes.

Authors:  Sacha Ferdinandusse; Simone Denis; Phyllis L Faust; Ronald J A Wanders
Journal:  J Lipid Res       Date:  2009-04-08       Impact factor: 5.922

Review 8.  Treatment of Smith-Lemli-Opitz syndrome and other sterol disorders.

Authors:  Melissa D Svoboda; Jill M Christie; Yasemen Eroglu; Kurt A Freeman; Robert D Steiner
Journal:  Am J Med Genet C Semin Med Genet       Date:  2012-10-05       Impact factor: 3.908

9.  Evidence from human and zebrafish that GPC1 is a biliary atresia susceptibility gene.

Authors:  Shuang Cui; Melissa Leyva-Vega; Ellen A Tsai; Steven F EauClaire; Joseph T Glessner; Hakon Hakonarson; Marcella Devoto; Barbara A Haber; Nancy B Spinner; Randolph P Matthews
Journal:  Gastroenterology       Date:  2013-01-18       Impact factor: 22.682

10.  Rapid quantification of conjugated and unconjugated bile acids and C27 precursors in dried blood spots and small volumes of serum.

Authors:  N Janzen; S Sander; M Terhardt; A M Das; J O Sass; R Kraetzner; H Rosewich; H Rosevich; M Peter; J Sander
Journal:  J Lipid Res       Date:  2010-01-21       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.